Jonathan Pollack, M.D., Ph.D.
| Stanford University | # of Grants: 2 |
Grants
| Genome-specific synthetic lethal targeting in lung cancer | 2009 (Cycle 18) | $400,000 |
| Cancer | Exploratory/Developmental Award | |
| TITF1 signature biomarkers for early lung cancer detection | 2012 (Cycle 21) | $343,799 |
| Early Diagnosis/Pathogenesis | Exploratory/Developmental Award | |
Publications